Navigation Links
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Date:5/22/2008

as improving efficacy, safety and compliance.

This press release contains forward-looking statements that reflect the company's current views as to its products, development programs, science and technology and business prospects. These forward-looking statements involve risks and uncertainties, including but not limited to: (i) the company's proprietary product candidates and those of certain of its partners are in the early phases of clinical development and the risk of failure is high and can occur at any stage prior to regulatory approval; (ii) the company's or its partner's ability to obtain regulatory approval for product candidates; (iii) the success of the company's partners in sales and marketing efforts to generate from approved products and future products (if any); and (iv) the company's patent applications for its technology platforms and proprietary or partner product candidates may not issue, patents that have issued may not be enforceable, or intellectual property licenses from third parties may be required in the future. Important risks and uncertainties are detailed in the company's reports and other filings with the Securities and Exchange Commission, including its most recent Quarterly Report on Form 10-Q filed on May 9, 2008. Actual results could differ materially from the forward-looking statements contained in this press release. The company undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Tim Warner (650) 283-4915 or twarner@nektar.com

Stephan Herrera (415) 488-7699 or sherrera@nektar.com

Jennifer Ruddock (650) 631-4954 or jruddock@nektar.com


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate $1 To Accelerate Cancer Research
2. Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries
3. Basil Zimmo Joins Finesse Solutions as Vice-President of Software
4. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
5. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
6. Harvey Morgan Joins CryoLife Board of Directors
7. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
8. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
9. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
10. Dr. Elizabeth Brown Joins Argenta TEC
11. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... EXTON, Pa., Nov. 21 ViroPharma Incorporated,(Nasdaq: ... chief,operating officer and chief financial officer of ViroPharma, ... Healthcare Conference at 3:30,P.M. ET on Tuesday, November ... the,New York Palace Hotel., ViroPharma also announced ...
... Oxford Genome Sciences,(UK) Ltd "OGeS" announces today ... and formerly Senior Vice President Corporate,Development at Biosite ... Christopher Hibberd brings over 15 years of experience ... is currently working as,CEO of Astute Medical, Inc. ...
... Royal,Society of Chemistry today announced the creation of the ... social development of,the continent. The Network, which will eventually ... Its purpose is to connect African,chemists more effectively and ... scientific development., Syngenta is supporting the launch with ...
Cached Biology Technology:ViroPharma to Present at Two Upcoming Healthcare Conferences 2Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors 2Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors 3Syngenta and The Royal Society of Chemistry Launch African Science Initiative 2Syngenta and The Royal Society of Chemistry Launch African Science Initiative 3
(Date:12/11/2014)... 2014  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in performance ... a staggering demand from its licensees for highly accurate, ... is not solely coming from fitness and health sectors, ... "A wearable is only as useful as the ...
(Date:12/10/2014)... DUBLIN , Dec. 08, 2014 Research and Markets ... of the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of biometrics and ... upgradation of the driver,s license is one of the ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... cows producing skimmed milk could soon be roaming our pastures, ... the SCI. Scientists in New Zealand have discovered that ... to produce skimmed milk and plan to use this information ... , The researchers also plan to breed commercial herds producing ...
... resonance imaging (MRI), radiologists can better predict the likelihood ... spinal cord injuries (SCI), according to a study published ... , "Our study demonstrates that the possibility and extent ... 48 hours after injury by rigorous assessment of MR ...
... have uncovered the basis by which pregnant women protect ... HIV virus works to counteract this defence. The research ... malaria-ravished regions. , Malaria is a parasitic disease spread ... every year. While the disease affects mostly children, malaria ...
Cached Biology News:Skimmed milk -- Straight from the cow 2Researchers use MRI to predict recovery after spinal cord injury 2HIV and malaria combine to adversely affect pregnant women and their infants 2
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
Porcine Coronary Artery Endothelial Cells (PCAEC) (>500,000 cells)...
...
Porcine Aortic Smooth Muscle Cells (PAOSMC) (>500,000 cells)...
Biology Products: